Skip to main content
Livermore
Livermore
ZHEN

Two Sigma Advisers, LP

SEC CIK
0001478735
Latest filing
Aug 14, 2026

BMRN holding history

Biomarin Pharmaceutical Inc in every 13F filed by Two Sigma Advisers, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BMRN overviewAll 13F holders of BMRNFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q2 2021
Holdings of BMRN by Two Sigma Advisers, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−49,200−100.0%Sold outHolders
Q4 202549,200$2.92M<0.1%+10,686+27.7%AddedHolders
Q3 202538,514$2.09M<0.1%−1,200−3.0%ReducedHolders
Q2 202539,714$2.18M<0.1%−427,600−91.5%ReducedHolders
Q1 2025467,314$33.0M0.1%+360,300+336.7%AddedHolders
Q4 2024107,014$7.03M<0.1%−74,300−41.0%ReducedHolders
Q3 2024181,314$12.7M<0.1%−50,600−21.8%ReducedHolders
Q2 2024231,914$19.1M<0.1%−313,100−57.4%ReducedHolders
Q1 2024545,014$47.6M0.1%+209,800+62.6%AddedHolders
Q4 2023335,214$32.3M0.1%−238,300−41.6%ReducedHolders
Q3 2023573,514$50.7M0.1%−176,600−23.5%ReducedHolders
Q2 2023750,114$65.0M0.2%−259,500−25.7%ReducedHolders
Q1 20231,009,614$98.2M0.3%+272,700+37.0%AddedHolders
Q4 2022736,914$76.3M0.2%+340,800+86.0%AddedHolders
Q3 2022396,114$33.6M0.1%+139,200+54.2%AddedHolders
Q2 2022256,914$21.3M0.1%+27,800+12.1%AddedHolders
Q1 2022229,114$17.7M<0.1%+118,100+106.4%AddedHolders
Q4 2021111,014$9.81M<0.1%+51,600+86.8%AddedHolders
Q3 202159,414$4.59M<0.1%−147,800−71.3%ReducedHolders
Q2 2021207,214$17.3M<0.1%+207,214NewHolders